Beth Wozniak, the Chair & CEO of $NVT, sold 7,597 shares of the company on 02-11-2026 for an estimated $884,822. We received data on the trade from a recent SEC filing. This was a sale of approximately 12.5% of their shares of this class of stock. Following this trade, they now own 52,989 shares of this class of $NVT stock.
$NVT Insider Trading Activity
$NVT insiders have traded $NVT stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $NVT stock by insiders over the last 6 months:
- SARA E ZAWOYSKI (President-Systems Protection) has made 0 purchases and 3 sales selling 115,557 shares for an estimated $13,032,059.
- BETH WOZNIAK (Chair & CEO) has made 0 purchases and 4 sales selling 54,065 shares for an estimated $5,117,671.
- LYNNETTE R HEATH (EVP & Chief HR Officer) has made 0 purchases and 2 sales selling 32,943 shares for an estimated $3,723,931.
- DER KOLK ROBERT J. VAN (President of EMEA and APAC) sold 21,500 shares for an estimated $2,513,178
- JERRY W BURRIS sold 5,244 shares for an estimated $588,743
- GREG SCHEU sold 5,591 shares for an estimated $581,687
- SUSAN M. CAMERON sold 5,000 shares for an estimated $572,600
- RANDOLPH A. WACKER (SVP & Chief Accounting Officer) sold 5,000 shares for an estimated $550,399
- DANITA K OSTLING sold 900 shares for an estimated $106,181
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NVT Hedge Fund Activity
We have seen 326 institutional investors add shares of $NVT stock to their portfolio, and 351 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS removed 3,847,016 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $392,280,221
- HOLOCENE ADVISORS, LP added 1,533,505 shares (+inf%) to their portfolio in Q3 2025, for an estimated $151,264,933
- MILLENNIUM MANAGEMENT LLC added 1,423,634 shares (+40.4%) to their portfolio in Q3 2025, for an estimated $140,427,257
- FRANKLIN RESOURCES INC removed 1,372,582 shares (-22.7%) from their portfolio in Q4 2025, for an estimated $139,962,186
- BALYASNY ASSET MANAGEMENT L.P. added 1,288,924 shares (+3467.1%) to their portfolio in Q3 2025, for an estimated $127,139,463
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 1,025,220 shares (-42.7%) from their portfolio in Q4 2025, for an estimated $104,541,683
- AMERICAN CENTURY COMPANIES INC removed 955,235 shares (-96.8%) from their portfolio in Q3 2025, for an estimated $94,224,380
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NVT Analyst Ratings
Wall Street analysts have issued reports on $NVT in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 11/20/2025
- Roth Capital issued a "Buy" rating on 11/03/2025
- Goldman Sachs issued a "Buy" rating on 11/03/2025
- Citigroup issued a "Buy" rating on 11/03/2025
- Keybanc issued a "Overweight" rating on 10/14/2025
- Barclays issued a "Overweight" rating on 10/01/2025
To track analyst ratings and price targets for $NVT, check out Quiver Quantitative's $NVT forecast page.
$NVT Price Targets
Multiple analysts have issued price targets for $NVT recently. We have seen 7 analysts offer price targets for $NVT in the last 6 months, with a median target of $133.0.
Here are some recent targets:
- Deane Dray from RBC Capital set a target price of $138.0 on 02/09/2026
- Julian Mitchell from Barclays set a target price of $141.0 on 02/09/2026
- Vladimir Bystricky from Citigroup set a target price of $133.0 on 02/09/2026
- Jeffrey Hammond from Keybanc set a target price of $130.0 on 02/09/2026
- Neal Burk from UBS set a target price of $128.0 on 11/20/2025
- Justin Clare from Roth Capital set a target price of $130.0 on 11/03/2025
- Joe Ritchie from Goldman Sachs set a target price of $140.0 on 11/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
